These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26950376)

  • 1. Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation.
    Varma A; Saliba RM; Torres HA; Afrough A; Hosing C; Khouri IF; Nieto Y; Shah ND; Parmar S; Bashir Q; Ahmed S; Jones RB; Kebriaei P; Olson AL; Shpall EJ; Alousi AM; Qazilbash MH; Champlin RE; Popat U
    Bone Marrow Transplant; 2016 Jul; 51(7):999-1001. PubMed ID: 26950376
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents.
    Kyvernitakis A; Mahale P; Popat UR; Jiang Y; Hosry J; Champlin RE; Torres HA
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):717-722. PubMed ID: 26712592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Complement Activating Collectins and Associated Serine Proteases in Patients With Hematological Malignancies, Receiving High-Dose Chemotherapy, and Autologous Hematopoietic Stem Cell Transplantations (Auto-HSCT).
    Świerzko AS; Michalski M; Sokołowska A; Nowicki M; Eppa Ł; Szala-Poździej A; Mitrus I; Szmigielska-Kapłon A; Sobczyk-Kruszelnicka M; Michalak K; Gołos A; Wierzbowska A; Giebel S; Jamroziak K; Kowalski ML; Brzezińska O; Thiel S; Jensenius JC; Kasperkiewicz K; Cedzyński M
    Front Immunol; 2018; 9():2153. PubMed ID: 30294330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors that predict delayed platelet recovery after autologous stem cell transplantation for lymphoma or myeloma.
    Nagayama T; Ashizawa M; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Mashima K; Umino K; Minakata D; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Yamamoto C; Fujiwara SI; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y
    Ann Hematol; 2020 Dec; 99(12):2893-2901. PubMed ID: 32572522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous hematopoietic cell transplantation for myeloma patients with hepatitis B virus or hepatitis C virus in the era of novel agents.
    Mizuno S; Takami A; Takamatsu H; Hanamura I; Shimazu Y; Hangaishi A; Tsukada N; Kako S; Kikuchi T; Ota S; Shimizu H; Iida S; Yoshioka S; Sawa M; Fukuda T; Kanda Y; Atsuta Y; Kawamura K
    Bone Marrow Transplant; 2022 May; 57(5):846-848. PubMed ID: 35332303
    [No Abstract]   [Full Text] [Related]  

  • 6. Collection, cryopreservation and autologous transplantation with circulating hemopoietic stem cells in patients with multiple myeloma and lymphoma.
    Adam M; Benbunan M; Fermand JP; Gisselbrecht C; Sitthy X; Maréchal B; Marchix T; Gerota J
    Bone Marrow Transplant; 1990 Jan; 5 Suppl 1():33-4. PubMed ID: 1969307
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical outcomes of hepatitis B or C virus infections in patients with malignant lymphoma receiving autologous stem cell transplantation: on behalf of the Adult Lymphoma Working Group of the Japan Society for Haematopoietic Cell Transplantation (JSHCT).
    Kato H; Kato K; Kim SW; Fukuda T; Mori T; Sawa M; Ohno Y; Yoshioka S; Iwato Y; Taji H; Onizuka M; Kurahashi S; Ichinohe T; Suzumiya J; Suzuki R
    Br J Haematol; 2019 Sep; 186(6):e170-e175. PubMed ID: 31206602
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan.
    Tsukune Y; Sasaki M; Odajima T; Sunami K; Takei T; Moriuchi Y; Iino M; Isoda A; Nakaya A; Muta T; Miyake T; Miyazaki K; Shimizu T; Nakajima K; Igarashi A; Nagafuji K; Kurihara T; Aoyama T; Sugimori H; Komatsu N
    Blood Cancer J; 2017 Nov; 7(12):631. PubMed ID: 29167420
    [No Abstract]   [Full Text] [Related]  

  • 9. Adequate Engraftment With Lower Hematopoietic Stem Cell Dose.
    Jeyaraman P; Borah P; Dayal N; Pathak S; Naithani R
    Clin Lymphoma Myeloma Leuk; 2020 Apr; 20(4):260-263. PubMed ID: 32019732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality patterns among recipients of autologous hematopoietic stem cell transplantation for lymphoma and myeloma in the past three decades.
    Bhatt VR; Loberiza FR; Jing H; Bociek RG; Bierman PJ; Maness LJ; Vose JM; Armitage JO; Akhtari M
    Clin Lymphoma Myeloma Leuk; 2015 Jul; 15(7):409-415.e1. PubMed ID: 25816932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors for a single successful cytapheresis session during the first mobilisation.
    Gac AC; Parienti JJ; Chantepie S; Cheze S; Johnson-Ansah H; Benabed K; Macro M; Lefevre V; Batho A; Fruchart C; Reman O
    Leuk Res; 2014 Sep; 38(9):1020-4. PubMed ID: 25073661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
    Varma A; Biritxinaga L; Saliba RM; Stich M; Jauch SF; Afrough A; Honhar M; Popat UR; Shafi MA; Shah N; Bashir Q; Dinh Y; Hosing C; Champlin RE; Qazilbash MH
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):581-587. PubMed ID: 28063964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus reactivation in lymphoma and myeloma patients undergoing autologous peripheral blood stem cell transplantation.
    Massoud R; Assi R; Fares E; Haffar B; Charafeddine M; Kreidieh N; Mahfouz R; Kanj SS; El Zakhem A; Kharfan-Dabaja M; Bazarbachi A; El Cheikh J
    J Clin Virol; 2017 Oct; 95():36-41. PubMed ID: 28843110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
    El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
    Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Cytomegalovirus Surveillance Necessary for Patients With Low Reactivation Risk in an Autologous Hematopoietic Cell Transplantation Setting?
    Kaya AH; Tekgunduz E; Akpinar S; Batgi H; Bekdemir F; Kayikci O; Namdaroglu S; Ulu BU; Dal MS; Cakar MK; Korkmaz S; Altuntas F
    Transplant Proc; 2017 Oct; 49(8):1911-1915. PubMed ID: 28923647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor autologous mobilization status does not impact on hematological recovery but affects outcome after allogeneic stem cell transplant for lymphoma and myeloma.
    Crocchiolo R; Chabannon C; El-Cheikh J; Esterni B; Lemarié C; Fürst S; Castagna L; Bouabdallah R; Ladaique P; Coso D; Schiano JM; Stoppa AM; Rey J; Ivanov V; Aurran T; Faucher C; Blaise D; Calmels B
    Leuk Lymphoma; 2013 Feb; 54(2):417-20. PubMed ID: 22702654
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of Performance Status and Hematopoietic Cell Transplantation Specific Comorbidity Index on Unplanned Admission Rates in Patients with Multiple Myeloma Undergoing Outpatient Autologous Stem Cell Transplantation.
    Obiozor C; Subramaniam DP; Divine C; Shune L; Singh AK; Lin TL; Abhyankar S; Chen GJ; McGuirk J; Ganguly S
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1641-1645. PubMed ID: 28603071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus infection and non-neutropenic fever after autologous stem cell transplantation: high rates of reactivation in patients with multiple myeloma and lymphoma.
    Fassas AB; Bolaños-Meade J; Buddharaju LN; Rapoport A; Cottler-Fox M; Chen T; Lovchik JC; Cross A; Tricot G
    Br J Haematol; 2001 Jan; 112(1):237-41. PubMed ID: 11167810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spontaneous remission of HCV infection after autologous stem cell transplantation in a 58-year-old man].
    Reinhardt L; Eiffert H; Wulf G; Ströbel P; Bremer SCB; Amanzada A; Ellenrieder V; Neesse A
    Internist (Berl); 2017 Jun; 58(6):621-625. PubMed ID: 28235985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced survival after autologous stem cell transplantation in myeloma and lymphoma patients with low vitamin D serum levels.
    Eicher F; Mansouri Taleghani B; Schild C; Bacher U; Pabst T
    Hematol Oncol; 2020 Oct; 38(4):523-530. PubMed ID: 32594534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.